Overall survival (OS) by line of therapy (LOT) in Medicare-enrolled glioblastoma multiforme (GBM) patients (pts).

被引：1
|
作者：
Aly, Abdalla
Singh, Prianka
Korytowsky, Beata
Dastani, Homa
Ling, Lisa
Botteman, Marc
Norden, Andrew David
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.2039
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2039
引用
收藏
页数：6
相关论文
共 50 条
  • [1] The association of pretreatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme (GBM).
    Bambury, Richard Martin
    Teo, MinYuen
    Yusuf, Anny
    Murray, Susan
    Battley, Jodie E.
    Drake, Catherine
    O'Dea, Pauline
    Bermingham, Niamh
    Keohane, Catherine
    O'Reilly, Seamus
    Power, Derek Gerard
    Moylan, Eugene J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [2] Bevacizumab and irinotecan in patients (pts) with recurrent glioblastoma multiforme (GBM)
    Raval, S.
    Hwang, S.
    Dorsett, L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [3] Glioblastoma Multiforme (GBM) in the Elderly: Initial Treatment Strategy and Overall Survival
    Glaser, S. M.
    Flickinger, J. C., Sr.
    Balasubramani, G. K.
    Beriwal, S.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E87 - E88
  • [4] Glioblastoma multiforme (GBM) in the elderly: initial treatment strategy and overall survival
    Scott M. Glaser
    Michael J. Dohopolski
    Goundappa K. Balasubramani
    John C. Flickinger
    Sushil Beriwal
    [J]. Journal of Neuro-Oncology, 2017, 134 : 107 - 118
  • [5] Glioblastoma multiforme (GBM) in the elderly: initial treatment strategy and overall survival
    Glaser, Scott M.
    Dohopolski, Michael J.
    Balasubramani, Goundappa K.
    Flickinger, John C.
    Beriwal, Sushil
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2017, 134 (01) : 107 - 118
  • [6] Long-term survival of patients with glioblastoma multiforme (GBM)
    Smoll, Nicolas R.
    Schaller, Karl
    Gautschi, Oliver P.
    [J]. JOURNAL OF CLINICAL NEUROSCIENCE, 2013, 20 (05) : 670 - 675
  • [7] OVERALL SURVIVAL (OS), QUALITY OF LIFE (QOL), AND NEUROCOGNITIVE FUNCTION (NF) IN RECURRENT GLIOBLASTOMA MULTIFORME (GBM): A SYSTEMATIC LITERATURE REVIEW
    Signorovitch, J.
    Li, N.
    Ohashi, E.
    Dastani, H.
    Shaw, J.
    Orsini, L.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A433 - A433
  • [8] Treatment Regimens and Duration of Lines of Therapy in Medicare-Enrolled Patients with Multiple Myeloma
    Yusuf, Akeem A.
    Natwick, Tanya
    Felici, Diana
    Werther, Winifred
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 527 - 527
  • [9] Superior overall survival (OS) and disease-free survival (DFS) predictions for patients with glioblastoma multiforme (GBM) using Cellworks Singula: myCare-022-03.
    Wen, Patrick Y.
    Castro, Michael
    Watson, Drew
    Kapoor, Shweta
    Agrawal, Ashish
    Alam, Aftab
    Roy, Kunal Ghosh
    Rajagopalan, Swaminathan
    Basu, Kabya
    Lala, Deepak Anil
    Mundkur, Nirjhar
    Christie, Jim
    Pampana, Anusha
    Basu, Sayani
    Sahu, Diwyanshu
    Narvekar, Yugandhara
    Singh, Divya
    Nair, Prashant
    Ahluwalia, Manmeet Singh
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [10] A RANDOMIZED, CONTROLLED TRIAL OF BERUBICIN VS. LOMUSTINE AFTER FIRST-LINE THERAPY FOR GLIOBLASTOMA MULTIFORME (GBM): INTERIM RESULTS OF A PRE-PLANNED ANALYSIS OF OVERALL SURVIVAL (OS)
    Silberman, Sandra
    Muzyczenko, Zena
    Hsu, Sigmund
    [J]. NEURO-ONCOLOGY, 2023, 25
12345